NCT02554526View on ClinicalTrials.gov

Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors

UnknownOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

December 31, 2017

Conditions
Hemophilia A With Inhibitor
Trial Locations (1)

634-8522

Department of Pediatrics, Kashihara

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

Nara Medical University

OTHER

NCT02554526 - Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors | Biotech Hunter | Biotech Hunter